RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 

RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization.

Stay informed on the latest healthcare regulatory news through RAPS’ online magazine, Regulatory Focus and its companion daily e-newsletter RF Today, or by following RAPS on social media, including TwitterLinkedIn and Facebook.

Reporters, bloggers and other members of the media interested in covering RAPS events or programs should contact Zachary Brousseau, senior manager of communications, at zbrousseau@raps.org or by calling +301 770 2920 ext. 245.

Press Releases

First virtual RAPS Convergence draws nearly 1,500 participants, earns praise

Posted 21 September 2020 | By Zachary Brousseau 

RAPS last week wrapped up its first RAPS Convergence conference to be held completely online. RAPS completely redesigned this year’s conference, transforming what has traditionally been a face...

RAPS recognizes new Fellows, Creaven-Capasso, Drago and McKeen

Posted 10 September 2020 | By Zachary Brousseau 

RAPS has announced the three outstanding senior regulatory professionals comprising the 2020 class of RAPS Fellows. The honor of being a RAPS Fellow is reserved for seasoned, proven leaders, w...

RAPS Announces 2020 Founder’s Award, Community Leadership Award and Patient-Centered Health Award Honorees

Posted 28 August 2020 | By Zachary Brousseau 

RAPS has announced six distinguished professionals and two influential organizations as this year’s honorees of RAPS’ awards for contributions to the regulatory profession and to promoting pub...

13 Earned Regulatory Affairs Certification (RAC) in midst of COVID-19 pandemic; Many others opt for future test date

Posted 28 July 2020 | By Zachary Brousseau 

Thirteen individuals passed the  RAC exam during the recent spring exam period, RAPS announced today. More than 90% of those who had initially registered to take the exam in the spring transfe...

Elemed and RAPS announce a partnership for Elemed’s Mentoring Academy

Posted 21 July 2020 | By Zachary Brousseau 

RAPS and Elemed have signed a partnership to offer Elemed’s first-of-its kind hybrid mentoring and training program for regulatory, quality and clinical professionals, to RAPS members at speci...

RAPS in the News

FDA delays collecting drugmaker data required by CARES Act | Becker's ASC Review

Posted 26 August 2020 | By Maia Anderson

...new data required from drugmakers under the Coronavirus Aid, Relief, and Economic Security Act next month, though the measure is set to take effect Sept. 23, Regulatory Focus reported.

V is for vaccine | The Star

Posted 22 August 2020

According to Regulatory Affairs Professional Society (RAPS), it will take a fast-tracked vaccine development anywhere between 12 and 18 months to be marketed commercially...

Pfizer Eyes Vaccine Race Finish Line | Investopedia

Posted 21 August 2020 | By Deborah D'Souza

Source: Regulatory Affairs Professionals Society...

FDA publicizes 20 device shortages, 1 discontinuation | Becker's ASC Review

Posted 17 August 2020 | By Angie Stewart

...required to notify the FDA of events that could disrupt the supply of a device during the public health emergency, according to the Regulatory Affairs Professionals Society.

The European Commission has reached a first agreement with AstraZeneca to purchase a potential vaccine against covid-19. | Delano

Posted 15 August 2020 | By Jess Bauldry

...19 vaccines are being developed around the world, according to the Regulatory Affairs Professional Society. Currently ...

     
  •  
  • 1
  •  
  • 2
  •  
  •